{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:37:13Z","timestamp":1778657833657,"version":"3.51.4"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The successful application of human gene therapy protocols on a broad clinical basis will depend on the availability of in vivo cell-type-specific gene delivery systems. We have developed retroviral vector particles, derived from spleen necrosis virus (SNV), that display the antigen binding site of an antibody on the viral surface. Using retroviral vectors derived from SNV that displayed single-chain antibodies (scAs) directed against a carcinoembryonic antigen-cross-reacting cell surface protein, we have shown that an efficient, cell-type-specific gene delivery can be obtained. In this study, we tested whether other scAs displayed on SNV vector particles can also lead to cell-type-specific gene delivery. We displayed the following scAs on the retroviral surface: one directed against the human cell surface antigen Her2neu, which belongs to the epidermal growth factor receptor family; one directed against the stem cell-specific antigen CD34; and one directed against the transferrin receptor, which is expressed on liver cells and various other tissues. We show that retroviral vectors displaying these scAs are competent for infection in human cells which express the antigen recognized by the scA. Infectivity was cell type specific, and titers above 10<jats:sup>5<\/jats:sup>CFU per ml of tissue culture supernatant medium were obtained. The density of the antigen on the target cell surface does not influence virus titers in vitro. Our data indicate that the SNV vector system is well suited for the development of a large variety of cell-type-specific targeting vectors.<\/jats:p>","DOI":"10.1128\/jvi.72.12.10148-10156.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T18:06:21Z","timestamp":1577815581000},"page":"10148-10156","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":51,"title":["Cell-Type-Specific Gene Transfer into Human Cells with Retroviral Vectors That Display Single-Chain Antibodies"],"prefix":"10.1128","volume":"72","author":[{"given":"An","family":"Jiang","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Division of Infectious Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania 19107,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Te-Hua T.","family":"Chu","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Infectious Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania 19107,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Nocken","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Paul Ehrlich Institut, 63225 Langen, Germany2"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Cichutek","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Paul Ehrlich Institut, 63225 Langen, Germany2"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Dornburg","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Infectious Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania 19107,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"591","article-title":"The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3","volume":"1","author":"Alper O.","year":"1990","unstructured":"Alper O. Yamaguchi K. Hitomi J. Honda S. Matsushima T. Abe K. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.Cell Growth Differ. 1 1990 591 599","journal-title":"Cell Growth Differ."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113409"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.4.2659-2663.1995"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.1.720-725.1997"},{"key":"e_1_3_2_6_2","first-page":"890","article-title":"Highly efficient eucaryotic gene expression vectors for peptide secretion","volume":"18","author":"Chu T.-H.","year":"1995","unstructured":"Chu T.-H. Martinez I. Olson P. Dornburg R. Highly efficient eucaryotic gene expression vectors for peptide secretion.BioTechniques 18 1995 890 899","journal-title":"BioTechniques"},{"key":"e_1_3_2_7_2","first-page":"292","article-title":"Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins","volume":"1","author":"Chu T.-H.","year":"1994","unstructured":"Chu T.-H. Martinez I. Sheay W. C. Dornburg R. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.Gene Ther. 1 1994 292 299","journal-title":"Gene Ther."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.133.1.157","article-title":"Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells","volume":"133","author":"Civin C. I.","year":"1984","unstructured":"Civin C. I. Strauss L. C. Brovall C. Fackler M. J. Schwartz J. F. Shaper J. H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.J. Immunol. 133 1984 157 163","journal-title":"J. Immunol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.11.040193.001501"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.1"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.4049\/jimmunol.136.11.4237","article-title":"Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes","volume":"136","author":"Cui Z.-Z.","year":"1986","unstructured":"Cui Z.-Z. Lee L. F. Silvia R. F. Witter R. L. Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes.J. Immunol. 136 1986 4237 4242","journal-title":"J. Immunol."},{"key":"e_1_3_2_12_2","first-page":"301","article-title":"Reticuloendotheliosis viruses and derived vectors","volume":"2","author":"Dornburg R.","year":"1995","unstructured":"Dornburg R. Reticuloendotheliosis viruses and derived vectors.Gene Ther. 2 1995 301 310","journal-title":"Gene Ther."},{"key":"e_1_3_2_13_2","first-page":"457","article-title":"From the natural evolution to the genetic manipulation of the host range of retroviruses","volume":"378","author":"Dornburg R.","year":"1997","unstructured":"Dornburg R. From the natural evolution to the genetic manipulation of the host range of retroviruses.Biol. Chem. 378 1997 457 468","journal-title":"Biol. Chem."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.7.3209-3212.1989"},{"key":"e_1_3_2_15_2","first-page":"927\u2013939","article-title":"Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention","volume":"5","author":"Dropubic B.","year":"1994","unstructured":"Dropubic B. Jeang K.-T. Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention.Hum. Gene Ther. 5 1994 927\u2013939 927\u2013930","journal-title":"Hum. Gene Ther."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-12-3251"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.9.5623-5628.1994"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90845-7"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.4.6.1172-1174.1984"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.5.2957-2962.1996"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.1147"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.7.4339-4346.1995"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.6-705"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(91)90404-I"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1990.1.1-5"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.62.070193.001203"},{"key":"e_1_3_2_27_2","first-page":"280","article-title":"Targeting of retroviral vectors through protease-substrate interactions","volume":"3","author":"Nilson B. H. K.","year":"1996","unstructured":"Nilson B. H. K. Morling F. J. Cosset F.-L. Russell S. J. Targeting of retroviral vectors through protease-substrate interactions.Gene Ther. 3 1996 280 286","journal-title":"Gene Ther."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.11097"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1073\/pnas.86.23.9079","article-title":"A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses","volume":"86","author":"Roux P.","year":"1989","unstructured":"Roux P. Jeanteur P. Piechaczyk M. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.Proc. Natl. Acad. Sci. USA 86 1989 9079 9083","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/21.5.1081"},{"key":"e_1_3_2_31_2","unstructured":"Sambrook J. Fritsch E. F. Maniatis T. Molecular cloning: a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Cold Spring Harbor N.Y"},{"key":"e_1_3_2_32_2","first-page":"334","article-title":"Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles","volume":"3","author":"Schnierle B. S.","year":"1996","unstructured":"Schnierle B. S. Moritz D. Jeschke M. Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.Gene Ther. 3 1996 334 342","journal-title":"Gene Ther."},{"key":"e_1_3_2_33_2","first-page":"856","article-title":"Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eucaryotic vectors","volume":"15","author":"Sheay W.","year":"1993","unstructured":"Sheay W. Nelson S. Martinez I. Chu T.-H. T. Dornburg R. Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eucaryotic vectors.BioTechniques 15 1993 856 861","journal-title":"BioTechniques"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4049\/jimmunol.148.1.267","article-title":"Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells","volume":"148","author":"Simmons D. L.","year":"1992","unstructured":"Simmons D. L. Satterthwaite A. B. Tennen D. G. Seed B. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells.J. Immunol. 148 1992 267 271","journal-title":"J. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.16.7570"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","unstructured":"Temin H. M. Retrovirus vectors for gene transfer: efficient integration into and expression of exogenous DNA in vertebrate cell genomes Gene transfer. Kucherlapati R. 1986 144 187 Plenum Press New York N.Y","DOI":"10.1007\/978-1-4684-5167-2_6"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(88)90535-1"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.3.2059-2064.1996"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.4.1811-1816.1993"},{"key":"e_1_3_2_40_2","first-page":"13","article-title":"Progress towards gene therapy for HIV infection","volume":"1","author":"Yu M.","year":"1994","unstructured":"Yu M. Poeschla E. Wong-Staal F. Progress towards gene therapy for HIV infection.Gene Ther. 1 1994 13 26","journal-title":"Gene Ther."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.72.12.10148-10156.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.72.12.10148-10156.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:03:55Z","timestamp":1695567835000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.72.12.10148-10156.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1128\/JVI.72.12.10148-10156.1998"],"URL":"https:\/\/doi.org\/10.1128\/jvi.72.12.10148-10156.1998","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]},"assertion":[{"value":"1998-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-09-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}